Mylan Inc. Executive Contends She Earned MBA from WVU

Stouffer, Rick, Tribune-Review/Pittsburgh Tribune-Review

Mylan Inc. executive Heather Bresch contends she had the approval
of the head of West Virginia University's executive MBA program to
substitute on-the-job training for the final 10 credits required for
her masters degree.

Instead, the current chief operating officer of Mylan continues
to come under scrutiny for allegedly being handed an MBA and thus
getting where she is due to her pedigree and who she knows.

Bresch is the daughter of West Virginia Gov. Joe Manchin, while
Mylan Chairman Mike Puskar is one of WVU's largest benefactors, and
current university President Mike Garrison is a childhood friend.

For the first time in 3-1/2 months since she stories about her
broke, Bresch on Tuesday told her side of a story she contends is
stems from West Virginia politics and academic ax-grinding.

"The reason I'm now coming out publicly is for three reasons,"
Bresch said, sitting in a meeting room at Mylan headquarters in the
Southpointe Office Park, in Cecil, Washington County, south of
Pittsburgh.

"I'm convinced that since this ordeal started last October, the
(Pittsburgh) Post-Gazette has been steadfast in not letting the
facts get in the way of a good story. I didn't want to speak out
until the panel (investigating whether Bresch earned an MBA nearly
10 years ago) was in place and I had testified before them, which I
did this past Sunday. And because I'm still the COO of a company
that last October was in the middle of a multibillion transaction
and I was focused on Mylan and our shareholders."

Bresch said she has only worked at Mylan since she left WVU, and
when she joined Mylan, her job didn't require a masters degree and
thus she never requested a college transcript.

"I had met in September 1998 with Dr. Paul Speaker, then the head
of the executive MBA program, and it is my understanding that at
that meeting he made the determination that all the work I then was
doing for Mylan -- handling all our dealings with a California
company called VivoRx, in which we had a $50 million investment, I
was running the biotechnology company, (because) we had ousted the-
then CEO -- all of that would substitute for the 10 credits I needed
in my final semester. …

The rest of this article is only available to active members of Questia

Print this page

While we understand printed pages are helpful to our users, this limitation is necessary
to help protect our publishers' copyrighted material and prevent its unlawful distribution.
We are sorry for any inconvenience.